1
|
Dama A, Baggio C, Trevisi L, Bolego C, Cignarella A. Regulation of human endothelial cell migration by oral contraceptive estrogen receptor ligands. Eur J Pharmacol 2023; 945:175591. [PMID: 36804546 DOI: 10.1016/j.ejphar.2023.175591] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2022] [Revised: 02/13/2023] [Accepted: 02/15/2023] [Indexed: 02/19/2023]
Abstract
Ethinylestradiol (EE) and estetrol (E4) are the two main estrogenic agents used in combined oral contraceptives. These compounds have different binding affinity to and efficacy on estrogen receptors (ER) subtypes. We previously reported that treatment with estrogenic agents enhances angiogenesis via nongenomic, G protein-coupled estrogen receptor (GPER)-dependent mechanisms. However, the impact of EE and E4 on human endothelial function has been little investigated. EE and E4 (10-9- 10-7 M) significantly enhanced migration of human umbilical vein endothelial cells (HUVECs) using scratch and Boyden chamber assays. Mechanistically, both agents increased accumulation of phosphorylated protein tyrosine kinase 2 on tyrosine 397 (FAK Y397), a key player in endothelial cell motility, after 30-min treatment. Treatment with increasing concentrations of EE, but not E4, enhanced accumulation of the glycolysis activator PFKFB3. Of note, effects of EE and E4 on endothelial migration and signalling proteins were abolished by addition of the GPER antagonist G36 (10-6 M). Thus, EE and E4 induced comparable endothelial responses in vitro, suggesting no apparent alterations of vascular remodelling and regeneration capacity by oral contraceptives containing these agents.
Collapse
Affiliation(s)
- Aida Dama
- Department of Medicine, University of Padova, Padova, Italy; Albanian University, Tirana, Albania
| | - Chiara Baggio
- Department of Medicine, University of Padova, Padova, Italy
| | - Lucia Trevisi
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy
| | - Chiara Bolego
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy
| | | |
Collapse
|
2
|
Kotha S, Solanke BU. Diversity Oriented Approach to New Tetrahedral Building Blocks by Ring‐Closing Metathesis. ChemistrySelect 2023. [DOI: 10.1002/slct.202204906] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Affiliation(s)
- Sambasivarao Kotha
- Department of Chemistry Indian Institute of Technology–Bombay Powai Mumbai 400 076 India
| | - Balaji U. Solanke
- Department of Chemistry Indian Institute of Technology–Bombay Powai Mumbai 400 076 India
| |
Collapse
|
3
|
Kotha S, Solanke BU. Modular Approach to Benzofurans, 2H-Chromenes and Benzoxepines via Claisen Rearrangement and Ring-Closing Metathesis: Access to Phenylpropanoids. Chem Asian J 2022; 17:e202200084. [PMID: 35218606 DOI: 10.1002/asia.202200084] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2022] [Revised: 02/25/2022] [Indexed: 11/07/2022]
Abstract
Benzofurans, 2 H -chromenes and benzoxepines are key structural elements present in several natural products and pharmaceuticals. Here, we describe an easy-to-execute strategy for the synthesis of benzofurans, 2 H -chromenes and benzoxepines, by employing Claisen rearrangement and ring-closing metathesis as key steps. A variety of phenols were converted into useful oxacycles in good to excellent yields. The ring-closing metathesis approach has been used to produce phenylpropanoid natural products. Examples described here include, the naturally occurring benzofurans such as 7-methoxywutaifuranal, 7-methoxywutaifuranol, 7-methoxywutaifuranate and the O -prenylated natural products like boropinic acid, boropinols A and C.
Collapse
Affiliation(s)
- Sambasivarao Kotha
- Indian Institute of Technology, Department of Chemistry, Powai, 400 076, Mumbai, INDIA
| | - Balaji U Solanke
- Indian Institute of Technology Bombay, Chemistry, 400076, Mumbai, INDIA
| |
Collapse
|
4
|
Characterization of novel heterocyclic compounds based on 4-aryl-4H-chromene scaffold as anticancer agents: Design, synthesis, antiprofilerative activity against resistant cancer cells, dual β-tubulin/c-Src inhibition, cell cycle arrest and apoptosis induction. Bioorg Chem 2021; 120:105591. [PMID: 34998122 DOI: 10.1016/j.bioorg.2021.105591] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2021] [Revised: 11/18/2021] [Accepted: 12/28/2021] [Indexed: 11/24/2022]
Abstract
In this study, three novel sets of 4-aryl-4H-chromene derivatives 4a-c, 6a-d and 7a-c were synthesized and evaluated for anticancer activity. Characterization of new compounds was established on basis of elemental analyses and spectral data. All new compounds were investigated for their antiproliferative activity against HCT-116, HepG-2 and MCF-7 cell lines using vinblastine and staurosporine as positive controls. Compounds 4b, 4c and 6d showed superior cytotoxicity against HCT-116, HepG-2 and MCF-7 cell lines, respectively with IC50 ranged from 3.31 to 4.95 μM. Additionally, compound 4b showed excellent cytotoxic activity (IC50 = 39.83 μM) against resistant HCT-116 better than doxorubicin (IC50 = 164.60 μM), while compounds 4c and 6d exhibited moderate cytotoxic activity against resistant HepG-2 and resistant MCF-7 cell lines. The most potent compounds inhibited both β-tubulin polymerization (IC50 = 8.78 - 16.47 μM) and c-Src kinase (IC50 = 0.07 - 0.18 μM) enzymes. Compounds 4b, 4c and 6d activated caspase-3, caspase-7, and caspase-9 proteins relative to untreated cells, revealing apoptosis induction. Apoptosis was also confirmed through up-regulation of Bax and down-regulation of Bcl-2 protein expression levels. Cell cycle analysis of compound 6d showed accumulation of cells in pre-G1 phase and cell cycle arrest at S phase in MCF-7 treated cells. As well 6d caused 7- and 63- fold increase in apoptotic cell population at early and late apoptosis stages. Finally, molecular modeling study was performed to predict the binding pattern of the target compounds inside c-Src kinase receptor.
Collapse
|
5
|
Rao MLN, Islam SS. Rearrangement-Driven Molecular Diversity: Synthesis of Functionalized Pyrones, Orthoesters, and Xanthones from Spiroketals. Org Lett 2021; 23:8668-8672. [PMID: 34714091 DOI: 10.1021/acs.orglett.1c02888] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The reaction of tricyclic 5,5-benzannulated spiroketals with trifluoroacetic acid (TFA) and AlCl3 furnished benzopyranobenzopyrans, benzofuro-orthoesters, and benzofuroxanthones. Whereas the reaction of tricyclic 5,5-benzannulated spiroketals with TFA produced the pyrones, the reaction with AlCl3 furnished densely functionalized orthoesters and xanthones. The formation of these products was rationalized by fascinating mechanistic pathways involving semipinacol/α-ketol molecular rearrangements.
Collapse
Affiliation(s)
- Maddali L N Rao
- Department of Chemistry, Indian Institute of Technology Kanpur, Kanpur 208016, India
| | - Sk Shamim Islam
- Department of Chemistry, Indian Institute of Technology Kanpur, Kanpur 208016, India
| |
Collapse
|
6
|
Awad SM, Mohamed MS, Khodair MAEF, El-Hameed RHA. Synthesis and Evaluation of Cytotoxic Activity of Certain Benzo[h]chromene Derivatives. Anticancer Agents Med Chem 2021; 21:963-986. [PMID: 32981512 DOI: 10.2174/1871520620666200925103742] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2020] [Revised: 07/21/2020] [Accepted: 08/08/2020] [Indexed: 11/22/2022]
Abstract
BACKGROUND Benzo[h]chromenes attracted great attention because of their widespread biological activities, including anti-proliferate activity, and the discovery of novel effective anti-cancer agents is imperative. OBJECTIVE The main objective was to synthesize new benzo[h]chromene derivatives and some reported derivatives, and then test all of them for their anti-cancer activities. METHODS The structures of the newly synthesized derivatives were confirmed by elemental and spectral analysis (IR, Mass, 1H-NMR and 13C-NMR). 35 compounds were selected by the National Cancer Institute (NCI) for single-dose testing against 60 cell lines and 3 active compounds were selected for 5-doses testing. Also, these 3 compounds were tested as EGFR-inhibitors; using sorafenib as standard, and as Tubulin polymerization inhibitors using colchicines as a standard drug. Moreover, molecular docking study for the most active derivative on these 2 enzymes was also carried out. RESULTS Compounds 1a, 1c and 2b have the highest activities among all 35 tested compounds especially compound 1c. CONCLUSION compound 1c has promising anti-cancer activities compared to the used standards and may need further modification and investigations.
Collapse
Affiliation(s)
- Samir M Awad
- Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Helwan University, Helwan, Cairo, Egypt
| | - Mosaad S Mohamed
- Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Helwan University, Helwan, Cairo, Egypt
| | | | - Rania H Abd El-Hameed
- Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Helwan University, Helwan, Cairo, Egypt
| |
Collapse
|
7
|
Guillemot-Legris O, Muccioli GG. The oxysterome and its receptors as pharmacological targets in inflammatory diseases. Br J Pharmacol 2021; 179:4917-4940. [PMID: 33817775 DOI: 10.1111/bph.15479] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2020] [Revised: 03/14/2021] [Accepted: 03/17/2021] [Indexed: 12/15/2022] Open
Abstract
Oxysterols have gained attention over the last decades and are now considered as fully fledged bioactive lipids. The study of their levels in several conditions, including atherosclerosis, obesity and neurodegenerative diseases, led to a better understanding of their involvement in (patho)physiological processes such as inflammation and immunity. For instance, the characterization of the cholesterol-7α,25-dihydroxycholesterol/GPR183 axis and its implication in immunity represents an important step in the oxysterome study. Besides this axis, others were identified as important in several inflammatory pathologies (such as colitis, lung inflammation and atherosclerosis). However, the oxysterome is a complex system notably due to a redundancy of metabolic enzymes and a wide range of receptors. Indeed, deciphering oxysterol roles and identifying the potential receptor(s) involved in a given pathology remain challenging. Oxysterol properties are very diverse, but most of them could be connected by a common component: inflammation. Here, we review the implication of oxysterol receptors in inflammatory diseases.
Collapse
Affiliation(s)
- Owein Guillemot-Legris
- Bioanalysis and Pharmacology of Bioactive Lipids Research Group, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium
| | - Giulio G Muccioli
- Bioanalysis and Pharmacology of Bioactive Lipids Research Group, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium
| |
Collapse
|
8
|
Subba Reddy CV, Sumathi S. l‐
Proline Catalyzed Synthesis of Highly Functionalized 4‐Hydroxy‐
4H
‐chromene‐pyrazoles and 4‐Hydroxy‐
4H
‐chromene‐barbiturates in Aqueous Medium. ChemistrySelect 2020. [DOI: 10.1002/slct.202001949] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Chitreddy V Subba Reddy
- Department of ChemistryVIT University Vellore 632014, Tamilnadu, Vellore India
- School of ChemistryThe Key Laboratory of Low-Carbon Chemistry & Energy Conservation of Guangdong Province, Sun Yat-sen University, No. 135 Xingangxi Road Guangzhou 510275, People's Republic of China
| | - Shanmugam Sumathi
- Department of ChemistryVIT University Vellore 632014, Tamilnadu, Vellore India
| |
Collapse
|
9
|
Ahmed HEA, El-Nassag MAA, Hassan AH, Okasha RM, Ihmaid S, Fouda AM, Afifi TH, Aljuhani A, El-Agrody AM. Introducing novel potent anticancer agents of 1H-benzo[f]chromene scaffolds, targeting c-Src kinase enzyme with MDA-MB-231 cell line anti-invasion effect. J Enzyme Inhib Med Chem 2018; 33:1074-1088. [PMID: 29923425 PMCID: PMC6022228 DOI: 10.1080/14756366.2018.1476503] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
In our effort to develop novel and powerful agents with anti-proliferative activity, two new series of 1H-benzo[f]chromene derivatives, 4a–h and 6a–h, were synthesised using heterocyclocondensation methodologies under microwave irradiation condition. The structures of the target compounds were established on the basis of their spectral data, IR, 1H NMR, 13 C NMR, 13 C NMR-DEPT/APT, and MS data. The new compounds have been examined for their anti-proliferative activity against three cancer cell lines, MCF-7, HCT-116, and HepG-2. Vinblastine and Doxorubicin have been used as positive controls in the viability assay. The obtained results confirmed that most of the tested molecules revealed strong and selective cytotoxic activity against the three cancer cell lines. Moreover, these molecules exhibited weak cytotoxicity on the HFL-1 line, which suggested that they might be ideal anticancer candidates. The SAR study of the new benzochromene compounds verified that the substituents on the phenyl ring of 1H-benzo[f]chromene nucleus, accompanied with the presence of bromine atom or methoxy group at the 8-position, increases the ability of these molecules against the different cell lines. Due to their high anti-proliferative activity, compounds 4c and 6e were selected to be examined their proficiency to inhibit the invasiveness of the highly sensitive and invasive breast cancer cell line, MDA-MB-231. The anti-invasion behaviour of these molecules against the highly sensitive, non-oestrogen, and progesterone MDA-MB-231 cell line gave rise to their decreasing metastatic effect compared to the reference drug. Furthermore, this report explores the apoptotic mechanistic pathway of the cytotoxicity of the target compounds and reveals that most of these compounds enhance the Caspase 3/7 activity that could be considered as potential anticancer agents.
Collapse
Affiliation(s)
- Hany E A Ahmed
- a Department of Pharmacy College, Pharmacognosy and Pharmaceutical Chemistry , Taibah University , Al-Madinah Al-Munawarah , Saudi Arabia.,b Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy , Al-Azhar University , Cairo , Egypt
| | - Mohammed A A El-Nassag
- c Chemistry Department, Faculty of Science , Al-Azhar University , Cairo , Egypt.,d Chemistry Department, Faculty of Science , Jazan University , Jazan , Saudi Arabia
| | - Ahmed H Hassan
- c Chemistry Department, Faculty of Science , Al-Azhar University , Cairo , Egypt.,d Chemistry Department, Faculty of Science , Jazan University , Jazan , Saudi Arabia
| | - Rawda M Okasha
- e Chemistry Department, Faculty of Science , Taibah University , Al-Madinah Al-Munawarah , Saudi Arabia
| | - Saleh Ihmaid
- a Department of Pharmacy College, Pharmacognosy and Pharmaceutical Chemistry , Taibah University , Al-Madinah Al-Munawarah , Saudi Arabia
| | - Ahmed M Fouda
- f Chemistry Department, Faculty of Science , King Khalid University , Abha , Saudi Arabia
| | - Tarek H Afifi
- e Chemistry Department, Faculty of Science , Taibah University , Al-Madinah Al-Munawarah , Saudi Arabia
| | - Ateyatallah Aljuhani
- e Chemistry Department, Faculty of Science , Taibah University , Al-Madinah Al-Munawarah , Saudi Arabia
| | - Ahmed M El-Agrody
- c Chemistry Department, Faculty of Science , Al-Azhar University , Cairo , Egypt
| |
Collapse
|
10
|
Zhang D, Hu W. Formal Carbene Insertion into C−O or C−N Bond: An Efficient Strategy for the Synthesis of 2-Substituted 2H
-Chromene Derivatives from Chromene Acetals or Hemiaminal Ethers. Adv Synth Catal 2018. [DOI: 10.1002/adsc.201800179] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Dan Zhang
- School of Pharmaceutical Sciences; Sun Yat-sen University; Guangzhou 510006 People's Republic of China
| | - Wenhao Hu
- School of Pharmaceutical Sciences; Sun Yat-sen University; Guangzhou 510006 People's Republic of China
| |
Collapse
|
11
|
Chang MY, Wu YS, Chen HY. CuI-Mediated Synthesis of Sulfonyl Benzofuran-3-ones and Chroman-4-ones. Org Lett 2018. [DOI: 10.1021/acs.orglett.8b00316] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Affiliation(s)
- Meng-Yang Chang
- Department of Medicinal and Applied Chemistry, Kaohsiung Medical University, Kaohsiung 807, Taiwan
- Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan
| | - Yan-Shin Wu
- Department of Medicinal and Applied Chemistry, Kaohsiung Medical University, Kaohsiung 807, Taiwan
| | - Han-Yu Chen
- Department of Medicinal and Applied Chemistry, Kaohsiung Medical University, Kaohsiung 807, Taiwan
| |
Collapse
|
12
|
Wang M, Tang BC, Xiang JC, Cheng Y, Wang ZX, Ma JT, Wu YD, Wu AX. C(sp3)–H Bond Functionalization of Benzo[c]oxepines via C–O bond Cleavage: Formal [3+3] Synthesis of Multisubstituted Chromans. J Org Chem 2018; 83:3409-3416. [DOI: 10.1021/acs.joc.8b00126] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Affiliation(s)
- Miao Wang
- Key Laboratory of Pesticide & Chemical Biology, Ministry of Education, College of Chemistry, Central China Normal University, Hubei, Wuhan 430079, P. R. China
| | - Bo-Cheng Tang
- Key Laboratory of Pesticide & Chemical Biology, Ministry of Education, College of Chemistry, Central China Normal University, Hubei, Wuhan 430079, P. R. China
| | - Jia-Chen Xiang
- Key Laboratory of Pesticide & Chemical Biology, Ministry of Education, College of Chemistry, Central China Normal University, Hubei, Wuhan 430079, P. R. China
| | - Yan Cheng
- Key Laboratory of Pesticide & Chemical Biology, Ministry of Education, College of Chemistry, Central China Normal University, Hubei, Wuhan 430079, P. R. China
| | - Zi-Xuan Wang
- Key Laboratory of Pesticide & Chemical Biology, Ministry of Education, College of Chemistry, Central China Normal University, Hubei, Wuhan 430079, P. R. China
| | - Jin-Tian Ma
- Key Laboratory of Pesticide & Chemical Biology, Ministry of Education, College of Chemistry, Central China Normal University, Hubei, Wuhan 430079, P. R. China
| | - Yan-Dong Wu
- Key Laboratory of Pesticide & Chemical Biology, Ministry of Education, College of Chemistry, Central China Normal University, Hubei, Wuhan 430079, P. R. China
| | - An-Xin Wu
- Key Laboratory of Pesticide & Chemical Biology, Ministry of Education, College of Chemistry, Central China Normal University, Hubei, Wuhan 430079, P. R. China
| |
Collapse
|
13
|
Panda P, Nayak S, Sahoo SK, Mohapatra S, Nayak D, Pradhan R, Kundu CN. Diastereoselective synthesis of novel spiro indanone fused pyrano[3,2-c]chromene derivatives following hetero-Diels–Alder reaction andin vitroanticancer studies. RSC Adv 2018; 8:16802-16814. [PMID: 35540554 PMCID: PMC9080297 DOI: 10.1039/c8ra02729c] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2018] [Accepted: 04/23/2018] [Indexed: 12/17/2022] Open
Abstract
Synthesis of novel spiro indanone fused pyrano[3,2-c]chromene derivatives following hetero-Diels–Alder reaction has been demonstrated and evaluated for theirin vitroanticancer activity.
Collapse
Affiliation(s)
- Pravati Panda
- Department of Chemistry
- Ravenshaw University
- Cuttack
- India
| | - Sabita Nayak
- Department of Chemistry
- Ravenshaw University
- Cuttack
- India
| | | | | | - Deepika Nayak
- Cancer Biology Division
- School of Biotechnology
- Kalinga Institutue of Industrial Technology
- Bhubaneswar
- India
| | - Rajalaxmi Pradhan
- Cancer Biology Division
- School of Biotechnology
- Kalinga Institutue of Industrial Technology
- Bhubaneswar
- India
| | - Chanakya Nath Kundu
- Cancer Biology Division
- School of Biotechnology
- Kalinga Institutue of Industrial Technology
- Bhubaneswar
- India
| |
Collapse
|
14
|
Chang MY, Chen HY, Chen YH. Synthesis of 2-Aryl-3-sulfonylchromans via Knoevenagel Condensation and Reduction Protocol. J Org Chem 2017; 82:12631-12639. [DOI: 10.1021/acs.joc.7b02392] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Meng-Yang Chang
- Department of Medicinal and Applied
Chemistry, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan
| | - Han-Yu Chen
- Department of Medicinal and Applied
Chemistry, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan
| | - Yu-Hsin Chen
- Department of Medicinal and Applied
Chemistry, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan
| |
Collapse
|
15
|
Phenylpyran-fused coumarin novel derivatives: combined photophysical and theoretical study on structural modification for PET-inhibited ICT emission. Struct Chem 2017. [DOI: 10.1007/s11224-017-1021-0] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
16
|
Ramakrishna E, Dev K, Kothari P, Tripathi AK, Trivedi R, Maurya R. Phytochemical investigation of Kigelia pinnata leaves and identification of osteogenic agents. Med Chem Res 2017. [DOI: 10.1007/s00044-017-1807-z] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
17
|
Costa M, Dias TA, Brito A, Proença F. Biological importance of structurally diversified chromenes. Eur J Med Chem 2016; 123:487-507. [PMID: 27494166 DOI: 10.1016/j.ejmech.2016.07.057] [Citation(s) in RCA: 183] [Impact Index Per Article: 22.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2015] [Revised: 06/21/2016] [Accepted: 07/23/2016] [Indexed: 12/20/2022]
Abstract
Compounds incorporating the chromene scaffold are largely present in natural products and display a wide variety of biological activities. Their low toxicity combined to the broad pharmacological properties have inspired medicinal chemists in the search for new therapeutic agents. This review covers the literature between 1993 and on the biological activity of 2H- and 4H-chromenes, both from natural and synthetic origin. Includes a section that identifies a selection of chromene-based natural products, followed by recent literature on bioactive natural chromenes and the corresponding source, covering plants and fruits. Synthetic chromenes are equally important and a separate section addresses the use of these derivatives as new leads for drug discovery. Different biological targets were identified, namely those associated with anticancer, antimicrobial, anti-inflammatory, antithrombotic and antipsychotic activities.
Collapse
Affiliation(s)
- Marta Costa
- Life and Health Sciences Research Institute (ICVS), University of Minho, Campus of Gualtar, Braga, Portugal; ICVS/3B's - PT Government Associate Laboratory, Braga, Guimarães, Portugal
| | - Tatiana A Dias
- Department of Chemistry, University of Minho, Campus of Gualtar, Braga, Portugal
| | - Alexandra Brito
- Department of Chemistry, University of Minho, Campus of Gualtar, Braga, Portugal
| | - Fernanda Proença
- Department of Chemistry, University of Minho, Campus of Gualtar, Braga, Portugal.
| |
Collapse
|
18
|
Shang XS, Li NT, Siyang HX, Liu PN. Palladium-Catalyzed Tandem Carbene Migratory Insertion and Intramolecular Cyclization: Synthesis of Chromeno[4,3-b]chromene Compounds. J Org Chem 2015; 80:4808-15. [DOI: 10.1021/acs.joc.5b00500] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Xue Song Shang
- Shanghai Key Laboratory of
Functional Materials Chemistry, Key Lab for Advanced Materials and
Institute of Fine Chemicals, East China University of Science and Technology, Meilong Road 130, Shanghai, China 200237
| | - Nian Tai Li
- Shanghai Key Laboratory of
Functional Materials Chemistry, Key Lab for Advanced Materials and
Institute of Fine Chemicals, East China University of Science and Technology, Meilong Road 130, Shanghai, China 200237
| | - Hai Xiao Siyang
- Shanghai Key Laboratory of
Functional Materials Chemistry, Key Lab for Advanced Materials and
Institute of Fine Chemicals, East China University of Science and Technology, Meilong Road 130, Shanghai, China 200237
| | - Pei Nian Liu
- Shanghai Key Laboratory of
Functional Materials Chemistry, Key Lab for Advanced Materials and
Institute of Fine Chemicals, East China University of Science and Technology, Meilong Road 130, Shanghai, China 200237
| |
Collapse
|
19
|
Paterni I, Granchi C, Katzenellenbogen JA, Minutolo F. Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential. Steroids 2014; 90:13-29. [PMID: 24971815 PMCID: PMC4192010 DOI: 10.1016/j.steroids.2014.06.012] [Citation(s) in RCA: 419] [Impact Index Per Article: 41.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Estrogen receptors alpha (ERα) and beta (ERβ) are nuclear transcription factors that are involved in the regulation of many complex physiological processes in humans. Modulation of these receptors by prospective therapeutic agents is currently being considered for prevention and treatment of a wide variety of pathological conditions, such as, cancer, metabolic and cardiovascular diseases, neurodegeneration, inflammation, and osteoporosis. This review provides an overview and update of compounds that have been recently reported as modulators of ERs, with a particular focus on their potential clinical applications.
Collapse
Affiliation(s)
- Ilaria Paterni
- Dipartimento di Farmacia, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy
| | - Carlotta Granchi
- Dipartimento di Farmacia, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy
| | - John A Katzenellenbogen
- Department of Chemistry, University of Illinois, 600 S. Mathews Avenue, Urbana, IL 61801, USA
| | - Filippo Minutolo
- Dipartimento di Farmacia, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy.
| |
Collapse
|
20
|
Esmati N, Foroughian M, Saeedi M, Mahdavi M, Khoshneviszadeh M, Firuzi O, Tanideh N, Miri R, Edraki N, Shafiee A, Foroumadi A. Synthesis and Cytotoxic Activity of Some Novel Dihyrobenzo[h]pyrano[3,2-c]chromene Derivatives. J Heterocycl Chem 2014. [DOI: 10.1002/jhet.1991] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Nasim Esmati
- Drug Design and Development Research Center; Tehran University of Medicinal Sciences; Tehran Iran
| | - Mahsa Foroughian
- Drug Design and Development Research Center; Tehran University of Medicinal Sciences; Tehran Iran
| | - Mina Saeedi
- Faculty of Pharmacy and Pharmaceutical Sciences Research Center; Tehran University of Medicinal Sciences; Tehran Iran
| | - Mohammad Mahdavi
- Faculty of Pharmacy and Pharmaceutical Sciences Research Center; Tehran University of Medicinal Sciences; Tehran Iran
| | - Mehdi Khoshneviszadeh
- Faculty of Pharmacy and Pharmaceutical Sciences Research Center; Tehran University of Medicinal Sciences; Tehran Iran
- Medicinal and Natural Product Chemistry Research Center; Shiraz University of Medical Sciences; Shiraz Iran
| | - Omidreza Firuzi
- Medicinal and Natural Product Chemistry Research Center; Shiraz University of Medical Sciences; Shiraz Iran
| | - Nader Tanideh
- Medicinal and Natural Product Chemistry Research Center; Shiraz University of Medical Sciences; Shiraz Iran
| | - Ramin Miri
- Medicinal and Natural Product Chemistry Research Center; Shiraz University of Medical Sciences; Shiraz Iran
| | - Najmeh Edraki
- Faculty of Pharmacy and Pharmaceutical Sciences Research Center; Tehran University of Medicinal Sciences; Tehran Iran
- Medicinal and Natural Product Chemistry Research Center; Shiraz University of Medical Sciences; Shiraz Iran
| | - Abbas Shafiee
- Faculty of Pharmacy and Pharmaceutical Sciences Research Center; Tehran University of Medicinal Sciences; Tehran Iran
| | - Alireza Foroumadi
- Drug Design and Development Research Center; Tehran University of Medicinal Sciences; Tehran Iran
- Faculty of Pharmacy and Pharmaceutical Sciences Research Center; Tehran University of Medicinal Sciences; Tehran Iran
| |
Collapse
|
21
|
Yadav P, Singh S, Sahu SN, Hussain F, Pratap R. Microwave assisted base dependent regioselective synthesis of partially reduced chromenes, isochromenes and phenanthrenes. Org Biomol Chem 2014; 12:2228-34. [DOI: 10.1039/c3ob41962b] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
22
|
Maximov PY, Lee TM, Jordan VC. The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice. CURRENT CLINICAL PHARMACOLOGY 2013; 8:135-55. [PMID: 23062036 PMCID: PMC3624793 DOI: 10.2174/1574884711308020006] [Citation(s) in RCA: 239] [Impact Index Per Article: 21.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/01/2012] [Revised: 07/11/2012] [Accepted: 10/03/2012] [Indexed: 01/13/2023]
Abstract
Selective estrogen receptor modulators (SERMs) are structurally different compounds that interact with intracellular estrogen receptors in target organs as estrogen receptor agonists or antagonists. These drugs have been intensively studied over the past decade and have proven to be a highly versatile group for the treatment of different conditions associated with postmenopausal women's health, including hormone responsive cancer and osteoporosis. Tamoxifen, a failed contraceptive is currently used to treat all stages of breast cancer, chemoprevention in women at high risk for breast cancer and also has beneficial effects on bone mineral density and serum lipids in postmenopausal women. Raloxifene, a failed breast cancer drug, is the only SERM approved internationally for the prevention and treatment of postmenopausal osteoporosis and vertebral fractures. However, although these SERMs have many benefits, they also have some potentially serious adverse effects, such as thromboembolic disorders and, in the case of tamoxifen, uterine cancer. These adverse effects represent a major concern given that long-term therapy is required to prevent osteoporosis or prevent and treat breast cancer. The search for the 'ideal' SERM, which would have estrogenic effects on bone and serum lipids, neutral effects on the uterus, and antiestrogenic effects on breast tissue, but none of the adverse effects associated with current therapies, is currently under way. Ospemifene, lasofoxifene, bazedoxifene and arzoxifene, which are new SERM molecules with potentially greater efficacy and potency than previous SERMs, have been investigated for use in the treatment and prevention of osteoporosis. These drugs have been shown to be comparably effective to conventional hormone replacement therapy in animal models, with potential indications for an improved safety profile. Clinical efficacy data from ongoing phase III trials are available or are awaited for each SERM so that a true understanding of the therapeutic potential of these compounds can be obtained. In this article, we describe the discovery and development of the group of medicines called SERMs. The newer SERMs in late development: ospemifene, lasofoxifene, bazedoxifene, are arzoxifene are described in detail.
Collapse
Affiliation(s)
- Philipp Y Maximov
- Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3970 Reservoir Rd NW, Research Building, Suite E204A, Washington, DC 20057, USA
| | - Theresa M Lee
- Division of Hematology and Oncology, Georgetown University Medical Center, 3970 Reservoir Rd NW, Washington, DC 20057, USA
| | - V. Craig Jordan
- Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3970 Reservoir Rd NW, Research Building, Suite E204A, Washington, DC 20057, USA
| |
Collapse
|
23
|
McDaniel RE, Maximov PY, Jordan VC. Estrogen-mediated mechanisms to control the growth and apoptosis of breast cancer cells: a translational research success story. VITAMINS AND HORMONES 2013; 93:1-49. [PMID: 23810002 DOI: 10.1016/b978-0-12-416673-8.00007-1] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
The treatment and prevention of solid tumors have proved to be a major challenge for medical science. The paradigms for success in the treatment of childhood leukemia, Hodgkin's disease, Burkett's lymphoma, and testicular carcinoma with cytotoxic chemotherapy did not translate to success in solid tumors--the majority of cancers that kill. In contrast, significant success has accrued for patients with breast cancer with antihormone treatments (tamoxifen or aromatase inhibitors) that are proved to enhance survivorship, and remarkably, there are now two approved prevention strategies using either tamoxifen or raloxifene. This was considered impossible 40 years ago. We describe the major clinical advances with nonsteroidal antiestrogens that evolved into selective estrogen receptor modulators (SERMs) which successfully exploited the ER target selectively inside a woman's body. The standard paradigm that estrogen stimulates breast cancer growth has been successfully exploited for over 4 decades with therapeutic strategies that block (tamoxifen, raloxifene) or reduce (aromatase inhibitors) circulating estrogens in patients to stop breast tumor growth. But this did not explain why high-dose estrogen treatment that was the standard of care to treat postmenopausal breast cancer for 3 decades before tamoxifen caused tumor regression. This paradox was resolved with the discovery that breast cancer resistance to long-term estrogen deprivation causes tumor regression with physiologic estrogen through apoptosis. The new biology of estrogen action has been utilized to explain the findings in the Women's Health Initiative that conjugated equine estrogen alone given to postmenopausal women, average age 68, will produce a reduction of breast cancer incidence and mortality compared to no treatment. Estrogen is killing nascent breast cancer cells in the ducts of healthy postmenopausal women. The modulation of the ER using multifunctional medicines called SERMs has provided not only significant improvements in women's health and survivorship not anticipated 40 years ago but also has been the catalyst to enhance our knowledge of estrogen's apoptotic action that can be further exploited in the future.
Collapse
Affiliation(s)
- Russell E McDaniel
- Department of Oncology, Georgetown University, Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA
| | | | | |
Collapse
|
24
|
Hossein nia R, Mamaghani M, Tabatabaeian K, Shirini F, Rassa M. An expeditious regioselective synthesis of novel bioactive indole-substituted chromene derivatives via one-pot three-component reaction. Bioorg Med Chem Lett 2012; 22:5956-60. [DOI: 10.1016/j.bmcl.2012.07.059] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2012] [Revised: 06/29/2012] [Accepted: 07/13/2012] [Indexed: 11/30/2022]
|
25
|
Magar DR, Chen K. Synthesis of substituted chiral chromans via organocatalytic kinetic resolution of racemic 3-nitro-2-aryl-2H-chromenes with ketones catalyzed by pyrrolidinyl-camphor-derived organocatalysts. Tetrahedron 2012. [DOI: 10.1016/j.tet.2012.05.019] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
26
|
Sashidhara KV, Kumar A, Agarwal S, Kumar M, Kumar B, Sridhar B. A Simple and Efficient Access to New Functionalized 4-Phenacylideneflavenes#. Adv Synth Catal 2012. [DOI: 10.1002/adsc.201100757] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
|
27
|
Fernández-Lodeiro J, Nuñez C, Carreira R, Santos HM, López CS, Mejuto JC, Capelo JL, Lodeiro C. Novel versatile imine—enamine chemosensor based on 6-nitro-4-oxo-4H-chromene for ion detection in solution, solid and gas-phase: synthesis, emission, computational and MALDI-TOF-MS studies. Tetrahedron 2011. [DOI: 10.1016/j.tet.2010.11.040] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
28
|
Purushothaman S, Prasanna R, Niranjana P, Raghunathan R, Nagaraj S, Rengasamy R. Stereoselective synthesis of hexahydro-3-methyl-1-arylchromeno[3,4-b]pyrrole and its annulated heterocycles as potent antimicrobial agents for human pathogens. Bioorg Med Chem Lett 2010; 20:7288-91. [DOI: 10.1016/j.bmcl.2010.10.073] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2010] [Revised: 09/24/2010] [Accepted: 10/15/2010] [Indexed: 10/18/2022]
|
29
|
Benfatti F, Benedetto E, Cozzi P. Organocatalytic Stereoselective α-Alkylation of Aldehydes with Stable Carbocations. Chem Asian J 2010; 5:2047-52. [DOI: 10.1002/asia.201000160] [Citation(s) in RCA: 96] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
30
|
Proença MF, Costa M. One-pot approach to the synthesis of novel 12H-chromeno[2′,3′:4,5]imidazo[1,2-a]pyridines in aqueous media. Tetrahedron 2010. [DOI: 10.1016/j.tet.2010.04.059] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
31
|
Xie JW, Fan LP, Su H, Li XS, Xu DC. Efficient kinetic resolution of racemic 3-nitro-2H-chromene derivatives catalyzed by Takemoto's organocatalyst. Org Biomol Chem 2010; 8:2117-22. [DOI: 10.1039/b922668k] [Citation(s) in RCA: 58] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
32
|
Jain N, Xu J, Kanojia RM, Du F, Jian-Zhong G, Pacia E, Lai MT, Musto A, Allan G, Reuman M, Li X, Hahn D, Cousineau M, Peng S, Ritchie D, Russell R, Lundeen S, Sui Z. Identification and structure-activity relationships of chromene-derived selective estrogen receptor modulators for treatment of postmenopausal symptoms. J Med Chem 2009; 52:7544-69. [PMID: 19366247 DOI: 10.1021/jm900146e] [Citation(s) in RCA: 74] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
As part of a program aimed at the development of selective estrogen receptor modulators (SERMs), novel chromene scaffolds, benzopyranobenzoxapanes, were discovered. Many compounds showed binding affinity as low as 1.6-200 nM, displayed antagonist behaviors in the MCF-7 human breast adenocarcinoma cell line as well in Ishikawa cell line with IC(50) values in the range 0.2-360 nM. On the basis of the side chain substitution, various compounds demonstrated strong inhibitory activity in anti-uterotropic assay. Compound 7-(R) and its major metabolites 5-(R) and 6-(R) were evaluated in several in vivo models of estrogen action. Relative to a full estrogen agonist (ethynyl estradiol) and the SERM raloxifene, 7-(R) was found to be a potent SERM that behaved as antagonist in the uterus and exhibited estrogen agonistic activity on bone, plasma lipids, hot flush, and vagina. The overall pharmacokinetic profile and stability were significantly improved compared to those of the phase 2 development compound 9-(R).
Collapse
Affiliation(s)
- Nareshkumar Jain
- Johnson & Johnson Pharmaceutical Research & Development LLC, 665 Stockton Drive, Exton, Pennsylvania 19341, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Peano BJ, Crabtree JS, Komm BS, Winneker RC, Harris HA. Effects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary gland. Endocrinology 2009; 150:1897-903. [PMID: 19022889 DOI: 10.1210/en.2008-1210] [Citation(s) in RCA: 82] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Selective estrogen receptor modulators (SERMs) are small molecules that, depending on the end point measured, may either function as estrogen receptor (ER) agonists or antagonize estrogens' agonist activity. A key feature of SERMs is the inhibition of ER agonist action on the uterus and mammary gland, but the degree of antagonism varies among compounds and end points. Bazedoxifene is a SERM that is being clinically evaluated both as a monotherapy for the prevention and treatment of osteoporosis and in combination with conjugated estrogens (CEs) for the treatment of menopausal symptoms and prevention of osteoporosis. The studies reported here compare the relative ER agonist and antagonist effects of three pharmacologically distinct SERMs (bazedoxifene, raloxifene, and lasofoxifene) on the ovariectomized mouse when administered alone or as a tissue-selective estrogen complex, a term used to describe the partnering of a SERM and one or more estrogens. At the minimum dose required to maximally reduce CE-stimulated uterine wet weight increase for each SERM, the degree of inhibition varied among the SERMs, with a rank order of bazedoxifene approximately raloxifene > lasofoxifene, in which only bazedoxifene was statistically similar to vehicle. In the mammary gland, in which amphiregulin mRNA and morphological effects were measured, bazedoxifene generally exhibited less agonist activity and was a more effective antagonist of CE than raloxifene or lasofoxifene. In summary, in an animal model evaluating estrogen-modulated uterine effects and mammary gland development, bazedoxifene exhibited less ER agonist activity than raloxifene or lasofoxifene, and, as a tissue-selective estrogen complex, bazedoxifene/CE demonstrated less mammary gland stimulation than raloxifene/CE and lasofoxifene/CE.
Collapse
Affiliation(s)
- Bryan J Peano
- Department of Women's Health and Musculoskeletal Biology, Wyeth Research, Collegeville, Pennsylvania 19426, USA.
| | | | | | | | | |
Collapse
|
34
|
|
35
|
Synthesis, biological evaluation, structural–activity relationship, and docking study for a series of benzoxepin-derived estrogen receptor modulators. Bioorg Med Chem 2008; 16:9554-73. [PMID: 18835176 DOI: 10.1016/j.bmc.2008.09.035] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2008] [Revised: 09/02/2008] [Accepted: 09/10/2008] [Indexed: 11/23/2022]
|
36
|
Tamoxifen: catalyst for the change to targeted therapy. Eur J Cancer 2008; 44:30-8. [PMID: 18068350 DOI: 10.1016/j.ejca.2007.11.002] [Citation(s) in RCA: 143] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2007] [Accepted: 11/02/2007] [Indexed: 11/20/2022]
Abstract
In the early 1970s, a failed post-coital contraceptive, ICI 46,474, was reinvented as tamoxifen, the first targeted therapy for breast cancer. A cluster of papers published in the European Journal of Cancer described the idea of targeting tamoxifen to patients with oestrogen receptor positive tumours, and proposed the strategic value of using long-term tamoxifen therapy in an adjuvant setting with a consideration of the antitumour properties of the hydroxylated metabolites of tamoxifen. At the time, these laboratory results were slow to be embraced by the clinical community. Today, it is estimated that hundreds of thousands of breast cancer patients are alive today because of targeted long-term adjuvant tamoxifen therapy. Additionally, the first laboratory studies for the use of tamoxifen as a chemopreventive were published. Eventually, the worth of tamoxifen was tested as a chemopreventive and the drug is now known to have an excellent risk benefit ratio in high risk pre-menopausal women. Overall, the rigorous investigation of the pharmacology of tamoxifen facilitated tamoxifen's ubiquitous use for the targeted treatment of breast cancer, chemoprevention and pioneered the exploration of selective oestrogen receptor modulators (SERMs). This new concept subsequently heralded the development of raloxifene, a failed breast cancer drug, for the prevention of osteoporosis and breast cancer without the troublesome side-effect of endometrial cancer noted in post-menopausal women who take tamoxifen. Currently, the pharmaceutical industry is exploiting the SERM concept for all members of the nuclear receptor superfamily so that medicines can now be developed for diseases once thought impossible.
Collapse
|
37
|
Meegan MJ, Barrett I, Zimmermann J, Knox AJS, Zisterer DM, Lloyd DG. Benzothiepin-derived molecular scaffolds for estrogen receptor modulators: synthesis and antagonistic effects in breast cancer cells. J Enzyme Inhib Med Chem 2008; 22:655-66. [PMID: 18035834 DOI: 10.1080/14756360701503232] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
Abstract
A series of novel benzothiepin-derived compounds are described as potent selective modulators of the human estrogen receptor (SERMs). The objective of the study is to evaluate the antiproliferative effects of the compounds on human MCF-7 breast tumor cells. These heterocyclic compounds contain the traditional triarylethylene arrangement exemplified by tamoxifen, conformationally restrained through the incorporation of the benzothiepin ring system. The compounds demonstrated potency at nanomolar concentrations in antiproliferative assays against an MCF-7 human breast cancer cell line with low cytotoxicity. The compounds exhibited low nanomolar binding affinity for the estrogen receptor (ER) with some specificity for ERbeta, and also demonstrate potent antiestrogenic properties in the human uterine Ishikawa cell line. The effect of a number of functional group substitutions on the ER binding properties of the benzothiepin molecular scaffold is explored through a brief computational structure-activity relationship investigation with molecular simulation.
Collapse
Affiliation(s)
- Mary J Meegan
- School of Pharmacy and Pharmaceutical Sciences, Centre for Synthesis and Chemical Biology, Trinity College Dublin, Dublin 2, Ireland.
| | | | | | | | | | | |
Collapse
|
38
|
Depré D, Horváth A, Snissaert W, Bergh LVD, Dermaut W. Implementation on Pilot-Plant Scale of the Titanocene-Catalyzed Reduction of a Lactone with Poly(methylhydrosiloxane). Org Process Res Dev 2007. [DOI: 10.1021/op700207m] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Dominique Depré
- Johnson and Johnson Pharmaceutical Research and Development, a Division of Janssen Pharmaceutica, API Development, Turnhoutseweg 30, B-2340 Beerse, Belgium
| | - András Horváth
- Johnson and Johnson Pharmaceutical Research and Development, a Division of Janssen Pharmaceutica, API Development, Turnhoutseweg 30, B-2340 Beerse, Belgium
| | - Walter Snissaert
- Johnson and Johnson Pharmaceutical Research and Development, a Division of Janssen Pharmaceutica, API Development, Turnhoutseweg 30, B-2340 Beerse, Belgium
| | - Leo Van Den Bergh
- Johnson and Johnson Pharmaceutical Research and Development, a Division of Janssen Pharmaceutica, API Development, Turnhoutseweg 30, B-2340 Beerse, Belgium
| | - Wim Dermaut
- Johnson and Johnson Pharmaceutical Research and Development, a Division of Janssen Pharmaceutica, API Development, Turnhoutseweg 30, B-2340 Beerse, Belgium
| |
Collapse
|
39
|
Li X, Reuman M, Russell RK, Youells S, Beish S, Hu Z, Branum S, Jain N, Sui Z. Synthesis of Tetracyclic Heterocompounds as Selective Estrogen Receptor Modulators. Part 2. Process Improvement for Scale-Up Of 2,5,8-Substituted 11,12-Dihydro-5H-6,13-dioxabenzo[3,4]cyclohepta-[1,2-a]naphthalene Derivatives. Org Process Res Dev 2007. [DOI: 10.1021/op700061x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Xun Li
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., U.S. Research & Early Development, 1000 Route 202, Raritan, New Jersey 08869, U.S.A
| | - Michael Reuman
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., U.S. Research & Early Development, 1000 Route 202, Raritan, New Jersey 08869, U.S.A
| | - Ronald K. Russell
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., U.S. Research & Early Development, 1000 Route 202, Raritan, New Jersey 08869, U.S.A
| | - Scott Youells
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., U.S. Research & Early Development, 1000 Route 202, Raritan, New Jersey 08869, U.S.A
| | - Sandra Beish
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., U.S. Research & Early Development, 1000 Route 202, Raritan, New Jersey 08869, U.S.A
| | - Zhiyong Hu
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., U.S. Research & Early Development, 1000 Route 202, Raritan, New Jersey 08869, U.S.A
| | - Shawn Branum
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., U.S. Research & Early Development, 1000 Route 202, Raritan, New Jersey 08869, U.S.A
| | - Nareshkumar Jain
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., U.S. Research & Early Development, 1000 Route 202, Raritan, New Jersey 08869, U.S.A
| | - Zhihua Sui
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., U.S. Research & Early Development, 1000 Route 202, Raritan, New Jersey 08869, U.S.A
| |
Collapse
|
40
|
Li X, Reuman M, Russell RK, Adams R, Ma R, Sandra Beish,, Branum S, Youells S, Roberts J, Jain N, Kanojia R, Sui Z. Synthesis of Tetracyclic Heterocompounds as Selective Estrogen Receptor Modulators. Part 1. Process Development for Scale-up of 2,5,8-Substituted 5,11-Dihydrochromeno[4,3-c]chromene Derivatives. Org Process Res Dev 2007. [DOI: 10.1021/op700020f] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Xun Li
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., U.S. Research & Early Development, 1000 Route 202, Raritan, New Jersey 08869
| | - Michael Reuman
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., U.S. Research & Early Development, 1000 Route 202, Raritan, New Jersey 08869
| | - Ronald K. Russell
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., U.S. Research & Early Development, 1000 Route 202, Raritan, New Jersey 08869
| | - Richard Adams
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., U.S. Research & Early Development, 1000 Route 202, Raritan, New Jersey 08869
| | - Robert Ma
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., U.S. Research & Early Development, 1000 Route 202, Raritan, New Jersey 08869
| | - Sandra Beish,
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., U.S. Research & Early Development, 1000 Route 202, Raritan, New Jersey 08869
| | - Shawn Branum
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., U.S. Research & Early Development, 1000 Route 202, Raritan, New Jersey 08869
| | - Scott Youells
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., U.S. Research & Early Development, 1000 Route 202, Raritan, New Jersey 08869
| | - Jerry Roberts
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., U.S. Research & Early Development, 1000 Route 202, Raritan, New Jersey 08869
| | - Nareshkumar Jain
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., U.S. Research & Early Development, 1000 Route 202, Raritan, New Jersey 08869
| | - Ramesh Kanojia
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., U.S. Research & Early Development, 1000 Route 202, Raritan, New Jersey 08869
| | - Zhihua Sui
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., U.S. Research & Early Development, 1000 Route 202, Raritan, New Jersey 08869
| |
Collapse
|
41
|
Chapter 10 Novel Selective Estrogen Receptor Modulators (SERMs). ANNUAL REPORTS IN MEDICINAL CHEMISTRY 2007. [DOI: 10.1016/s0065-7743(07)42010-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/08/2023]
|
42
|
Chen N, Jain N, Xu J, Reuman M, Li X, Russell RK, Sui Z. Synthesis of novel tetracyclic chromenes through carbanion chemistry of 4-methyl coumarins. Tetrahedron Lett 2006. [DOI: 10.1016/j.tetlet.2006.06.047] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|